July 5, 2017 / 11:45 AM / 3 months ago

BRIEF-Endo divests Grupo Farmacéutico SOMAR in $124 mln deal

July 5 (Reuters) - Endo International Plc

* Endo announces divestiture of grupo farmacéutico somar

* Endo announces divestiture of grupo farmacéutico somar

* Endo international plc - deal for ‍approximately $124 million​

* Says ‍to sell mexico city based grupo farmacéutico somar to advent international for approximately $124 million​

* Endo international plc - deal for approximately $124 million

* Endo international plc - endo intends to classify somar assets and liabilities as held-for-sale in second-quarter 2017

* Endo international plc - expects to record estimated pre-tax impairment charge of approximately $100 million

* Endo international- will finalize analysis and record any required impairment charges in connection with second-quarter 2017 financial reporting close​

* Endo international - will finalize analysis,record required impairment charges in connection with its second-quarter 2017 financial reporting close Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below